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The use of linked routine data to optimise calculation of the 
Hospital Frailty Risk Score on the basis of previous hospital 
admissions: a retrospective observational cohort study
Andrew Street, Laia Maynou, Thomas Gilbert, Tony Stone, Suzanne Mason, Simon Conroy
Summary
Background The Hospital Frailty Risk Score (HFRS) has been widely but inconsistently applied in published studies, 
particularly in how diagnostic information recorded in previous hospital admissions is used in its construction. 
We aimed to assess how many previous admissions should be considered when constructing the HFRS and the 
influence of frailty risk on long length of stay, in-hospital mortality, and 30-day readmission.
Methods This is a retrospective observational cohort study of patients aged 75 years or older who had at least one 
emergency admission to any of 49 hospital sites in the Yorkshire and Humber region of England, UK. We constructed 
multiple versions of the HFRS for each patient, each form incorporating diagnostic data from progressively more 
previous admissions in its construction within a 1-year or 2-year window. We assessed the ability of each form of the 
HFRS to predict long length of stay (>10 days), in-hospital death, and 30-day readmission.
Findings Between April 1, 2013, and March 31, 2017, 282 091 patients had 675 155 hospital admissions. Regression 
analyses assessing the different constructions of HFRS showed that the form constructed with diagnostic information 
recorded in the current and previous two admissions within the preceding 2 years performed best for predicting all 
three outcomes. Under this construction, 263 432 (39·0%) of 674 615 patient admissions were classified as having low 
frailty risk, for whom 33 333 (12·7%) had a long length of stay, 10 145 (3·9%) died in hospital, and 45 226 (17·2%) 
were readmitted within 30 days. By contrast with those patients with low frailty risk, for those with intermediate 
frailty risk, the probability was 2·5-times higher (95% CI 2·4 to 2·6) for long length of stay, 2·17-times higher 
(2·1 to 2·2) for in-hospital death, and 0·7% higher (0·5 to 1) for readmission. For patients with high frailty risk, the 
probability was 4·3-times higher (4·2 to 4·5) for long length of stay, 2·48-times higher (2·4 to 2·6) for in-hospital 
death, and –1% (–1·2 to –0·5) lower for readmission than those with low frailty risk. The intermediate and high frailty 
risk categories were more important predictors of long length of stay than any of the other rich set of control variables 
included in our analysis. These categories also proved to be important predictors of in-hospital mortality, with only 
the Charlson Comorbidity Index offering greater predictive power. 
Interpretation We recommend constructing the HFRS with diagnostic information from the current admission and 
from the previous two admissions in the preceding 2 years. This HFRS form was a powerful predictor of long length 
of stay and in-hospital mortality, but less so of emergency readmissions.
Funding National Institute of Health Research.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Health systems worldwide are interested in identifying 
frailty in patients. Two widely used tools include the 
electronic Frailty Index (in primary care)1 and the Hospital 
Frailty Risk Score (HFRS; in secondary care).2 Gilbert and 
colleagues2 developed the HFRS focusing on individuals 
aged 75 years or older who are at greatest risk of harm and 
high resource use in hospital. This risk score takes values 
ranging from 0 (no frailty risk) to 173·2 and is calculated 
by combining a weighted set of 109 three-character 
diagnostic codes from the International Statistical 
Classification of Diseases and Related Health Problems, 
tenth revision (ICD-10), recorded during the current 
admission and any previous emergency admissions 
occurring in the preceding 2 years.
The HFRS has been widely adopted, but diagnostic 
information from past admissions is inconsistently 
used.3–21 At face value, using more information is always 
better, increasing the likelihood that the HFRS captures 
the true effect of frailty risk on patient outcomes. 
However, obtaining historical data might incur costs and, 
even if these costs were marginal, they might not be 
worth incurring if the extra data do not offer substantial 
additional information. 
There are two forms of inconsistency in constructing the 
HFRS. First, variation occurs in the so-called look-back 
window (how far back to go in health records to search for 
data) in accounting for previous admissions. Some studies 
apply a 2-year window,3–6 as recommended by Gilbert and 
colleagues.2 Some studies use information from the 
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current admission alone,7–10 whereas others look back over 
the preceding 3 months,11,12 the preceding year,13,14 and even 
up to the preceding 15 years.15,16 In some studies, the look-
back period is not specified.17–19 This variation in defining 
the look-back period entails a lack of external consistency 
in how the HFRS is constructed, compromising the 
comparison of findings across studies.
Second, studies will have internal inconsistency when 
constructing the HFRS if the look-back window had 
been defined by the period covered by the dataset but 
varied for individuals in the dataset.20,21 Take a 2-year 
dataset, for instance: if a patient died at the start of 
these 2 years, they might only have a single record even 
though they might have been in hospital several times 
in the year or two before the start of the period covered 
by the data. For such an individual, their previous 
admissions would be unobserved and their frailty risk 
would be understated. By contrast, for a patient 
admitted towards the end of the data period, the frailty 
risk would be measured as intended by Gilbert and 
colleagues.2 In such applications, the HFRS will not be 
constructed consistently across patients in the same 
study.
In this study, we aimed to provide definitive guidance 
about how best to construct the HFRS both in terms of 
the number of previous admissions from which 
diagnostic data are extracted and the length of the look-
back period so that the risk score can be used to predict 
accurately the probabilities of long length of stay 
(>10 days), dying in hospital, and 30-day readmission. 
To determine this minimum amount of previous 
admissions, we aimed to construct multiple forms of the 
HFRS and assessed their ability to predict long length 
of stay, in-hospital death, and 30-day emergency 
readmission. To assess the accuracy of HFRS predictions, 
we aimed to use a richer set of control variables than that 
used in the original HFRS study or in any other study 
that has since validated the HFRS. These control 
variables include patients’ sociodemographic and clinical 
characteristics and their journey along the emergency 
and urgent care pathway before their admission to 
hospital. 
Methods 
Study setting and participants 
We did a retrospective cohort study of individuals aged 
75 years or older who had at least one emergency 
admission to any of the 49 sites of the 13 acute National 
Health Service (NHS) hospitals in the Yorkshire and 
Humber region of England (UK), with a population of 
5·4 million people and a mixture of large and small urban, 
suburban, and rural settings. The Connected Health 
Cities Urgent and Emergency Care Research database 
(CUREd)22 collates routine data from NHS 111 service, the 
Yorkshire Ambulance Service computer-aided dispatch 
data, and the emergency department and inpatient patient 
administration systems. The full dataset runs from 
April 1, 2011, to March 31, 2017, but we ran the analyses 
from April 1, 2013, onwards so that the HFRS was always 
constructed consistently with use of a full 2-years’ worth of 
historical data for all patients.
Study design
In the first stage of the analyses, each patient was 
categorised as having low (HFRS <5), intermediate 
(5–15) or high (>15) frailty risk by constructing the HFRS 
Research in context
Evidence before this study
We searched ResearchGate, ScienceDirect, Google scholar, and 
ClinicalTrials.gov using the search terms “Hospital Frailty Risk 
Score” (HFRS) and “HFRS” for studies in English published up to 
Oct 2, 2020, to identify studies that applied the HFRS to 
patients aged 75 or older to assess how past diagnostic data 
was used in its construction. Authors were contacted if these 
details were not reported in the article. We found that the HFRS 
has been widely but inconsistently applied, with studies 
differing in the use of diagnostic data from past emergency 
admissions when constructing the risk score.
Added value of this study
Our study offers two major contributions. First, we established 
what constitutes the minimum amount of diagnostic data 
from previous admissions required to construct the HFRS. 
More information offers better predictive accuracy, whether the 
estimated effects are larger or smaller than those based on less 
information, but historical data might be difficult to access. We 
determined the point at which there is no significant change in 
predictive ability, beyond which historical data are not worth 
accounting for. To determine this point, we constructed 
multiple forms of the HFRS and assessed their ability to predict 
long length of stay, in-hospital death, and 30-day emergency 
readmission. Second, we assessed the importance of the HFRS 
in predicting patient outcomes compared with a richer set of 
control variables than that used in the original HFRS study or in 
any other study that has since validated the HFRS, including 
patients’ sociodemographic and clinical characteristics and their 
journey along the emergency and urgent care pathway before 
their admission to hospital.
Implications of all the available evidence
The HFRS should be constructed with diagnostic information 
recorded in the current and previous two admissions within the 
preceding 2 years, as diagnostic data from additional previous 
admissions did not add predictive value. The HFRS is a powerful 
predictor of long length of stay and in-hospital death, but not 
of 30-day readmission.
Articles
www.thelancet.com/healthy-longevity   Vol 2   March 2021 e156
with use of diagnostic information from the current 
admission alone (labelled HFRS(a)). We then ran 
regression analyses to assess the association between 
frailty risk and of long length of stay, in-hospital mortality, 
and 30-day emergency readmission, taking into account 
various control variables, including category variables for 
the intermediate-risk group (labelled HFRSi) and the 
high-risk group (labelled HFRSh), with patients in the 
low-risk group serving as the reference category.
In the second stage, we investigated how each 
individual’s categorisation by frailty risk changed as 
progressively more past admissions occurring in the 
preceding year were considered in the construction of the 
HFRS. The second form of the HFRS, HFRS(a + 1,1), 
captured diagnostic data from both the current and one 
previous admission (labelled a + 1) that occurred within 
the preceding year (labelled 1). The third form, 
HFRS(a + 2,1), included data from the current and previous 
two admissions occurring in the preceding year, and so 
on. One patient had 39 admissions in the year preceding 
their current admission, and this was captured by the 
final HFRS(a + n,1) form.
To arrive at the preferred form of the HFRS, we assessed 
whether a significant (p<0·05) difference occurred in the 
point estimates associated with the high-risk frailty 
category under successive constructions of the HFRS, 
following the process set out in the top half of figure 1. If 
the point estimate from HFRSh(a + 1,1) fell within the 95% CI 
of the point estimate for HFRSh(a), then the HFRS(a) 
construction was preferred, as the extra diagnostic data of 
HFRSh(a + 1,1) did not increase the predictive ability compared 
with the use of fewer data. If not, we assessed whether the 
estimate for HFRSh(a + 2,1) fell within the 95% CI of the 
estimate for HFRSh(a + 1,1), and so on.
In the third stage, we repeated the preceding analyses 
after widening the look-back window in which previous 
admissions occurred to 2 years before the current 
admission, as set out in the lower half of figure 1. 
To determine whether to use a 1-year or 2-year look-back 
window, the 1-year version of the HFRS preferred in the 
second stage of analysis (eg, HFRS(a + 1,1)) was compared 
with its 2-year window version (eg, HFRS(a + 1,2)). If the point 
estimate from the 2-year version (eg, HFRSh(a + 1,2)) was 
within the 95% CI of the 1-year version, then the 1-year 
version was preferred. If not, the 2-year version was 
preferred because this additional diagnostic data yielded a 
significantly different estimate of the effect of frailty risk 
on each outcome. We also did a sensitivity analysis that 
assessed whether a 3-year window added predictive 
accuracy.
Statistical analysis
The regression models took the general form
where Y indicates one of three outcomes: long length of 
stay, in-hospital death, or 30-day emergency readmission. 
We used a Logit model for long length of stay, a Cox 
proportional hazard model for in-hospital death, and a 
sample selection bivariate probit model for 30-day 
readmission. As detailed in the appendix (p 4), the probit 
model for readmission recognises that in-hospital 
mortality is a competing risk for 30-day readmission and 
conditions the probability of readmission on whether the 
patient survived the previous hospitalisation.23 This 
involved first estimating a selection equation to 
explain the probability of survival before estimating the 
probability of re admission. This survival model accounts 
for the day of the admission, the argument being that the 
day of admission influences in-hospital mortality but has 
no bearing on the probability of readmission.23
If the regression coefficients for HFRSi and HFRSh were 
positive and significant, those patients with intermediate 
and high frailty risk had a higher likelihood of long length 
of stay (captured by odds ratios [ORs]), in-hospital 
death (captured by hazard ratios [HRs]), or emergency 
readmission (captured by average marginal effects) than 
patients assessed as having low frailty risk.
The regression analyses controlled for sociodemographic 
and clinical characteristics of patients, indicated by vector 
X, including age, sex, socio economic status, Charlson 
Comorbidity Index,24 number of emerg ency admissions in 
the preceding year, counts of the number of operation 
Figure 1: Decision rules to arrive at preferred form of HFRS
(a)=current admission only. (a + n,1)=current admission and n previous admissions in the preceding year. 
HFRS=Hospital Frailty Risk Score.
Study stage 2: with 1-year look-back window, for each outcome, run regressions with different forms of the HFRS 
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See Online for appendix
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codes, whether or not they had ambulatory care-sensitive 
conditions (ACSC), the national tariff attached to the 
Healthcare Resource Group to which they were 
categorised, whether they were care home residents, and 
travel time between their residence and the hospital 
(appendix p 2).
Length of stay (OR) In-hospital deaths (HR) 30-day readmission (AME)
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Data are coefficients (95% CI), using low frailty risk as the reference category and after adjusting for all control variables. OR=odds ratio. HFRS=Hospital Frailty Risk Score. 
HR=hazard ratio. AME=average marginal effect. *Coefficient is significant (p<0·05). 





HFRS(a) categorisation 373 799 (55·4%) 251 009 (37·2%) 49 807 (7·4%)
Outcomes
Length of stay (>10 days) 177 255/674 615 26·3% (44·1) 13·9% (34·6) 37·1% (48·3) 64·6% (47·8)
In-hospital death 51 569/675 155 7·6% (26·6) 4·5% (20·8) 10·8% (31·1) 15·1% (35·7)
Readmission 130 717/675 155 19·4% (39·5) 19·2% (39·4) 19·9% (39·9) 17·7% (38·2)
Data are n/N, n (%), or % (SD). In-hospital death was recorded for all observations. Discharge date was missing for 540 (0·1%) patients, for whom neither long length of stay 
nor the HFRS could be calculated, but they were included in the readmission analysis on the assumption that were not readmitted within 30 days. Of the 18 145 patients 
discharged after March 1, 2017, 1706 (9·4%) were readmitted before March 31, 2017, compared with a monthly average of 19·4% for the study period. The remaining 
censored observations were assumed not to have been readmitted within 30 days. HFRS=Hospital Frailty Risk Score. (a)=data from current admission alone.
Table 1: Descriptive statistics of outcomes, 2013–17
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Vector P includes variables capturing the patient’s 
emergency and urgent care journey before admission: the 
number and length in minutes of the individual’s emergency 
(NHS 111 and 999) calls, time of the ambulance on scene, 
time taken between calling the ambulance and arrival at the 
emergency department, the urgency with which the 
ambulance was dispatched, and whether the patient was 
admitted to hospital through the emergency department.
Variables indicating day, month, and year of admission 
were included in vector T. We included a fixed effect for 
each of the 49 hospital sites, represented as vector Z. For 
long length of stay and 30-day readmission, SEs were 
clustered at patient level to capture correlation across 
multiple admissions, perhaps to different hospital sites, 
by the same patient. Statistical analysis was done with 
Stata 15.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. 
Results
The analysis sample comprised 282 091 patients who had 
675 155 hospital admissions between April 1, 2013, and 
March 31, 2017. In-hospital death was recorded for all 
observations, discharge date was missing for 540 (0·1%) 
admissions for which neither long length of stay nor 
the HFRS could be calculated, and those patients 
censored at March 31, 2017, were assumed not to have 
been readmitted within 30 days. 177 255 (26·3%) of 
674 615 observations had a long length of stay, 
51 569 (7·6%) of 675 155 died in hospital, and 
130 717 (19·4%) of 675 155 had an emergency readmission 
within 30 days of being discharged (table 1; summary 
statistics across all observations for each of the control 
variables are reported in appendix p 3). Regarding the 
HFRS(a) frailty risk categorisation, 373 799 (55·4%) 
of 674 615 admissions were in the low category, 
251 009 (37·2%) in the intermediate category, and 
49 807 (7·4%) in the high category (table 1).
The first stage of the study involved regression analysis 
of each of the three outcomes in turn, with frailty risk 
defined under the HFRS(a) construction and including 
the control variables (full set of results in appendix p 6). 
Compared with patients with low frailty risk, those with 
intermediate risk were 2·66-times more likely to have a 
long length of stay and 1·96-times more likely to die in 
hospital, but 0·3% less likely to be readmitted within 
30 days; those with high frailty risk were 5·47-times more 
likely to have a long length of stay, 2·24-times more likely 
to die in hospital, but 2·7% less likely to be readmitted 
within 30 days (table 2).
In the second stage, we repeated the regression 
analyses, progressively substituting the intermediate and 
high frailty risk categories constructed based on 
HFRS(a) for constructions based on HFRS(a + 1,1), HFRS(a + 2,1), 
HFRS(a + 3,1), HFRS(a + 4,1), and HFRS(a + n,1), using increasingly 
more previous admissions occurring in the preceding 
year. The proportion of patients in the low frailty risk 
category decreased and the proportion of those in the 
high-risk category increased as data from progressively 
more historical admissions was used to construct the 
HFRS (table 3).
We plotted the proportion of patients in the high frailty 
risk category against the OR (95% CI) for long length of 
stay under each version of the HFRS (figure 2A). When 
adding one previous admission within a 1-year window 
to the current admission for the construction of the 
HFRS (HFRS(a + 1,1)), the proportion of patients with high 
frailty risk increased and the adjusted OR decreased 
significantly (OR of HFRSh(a + 1,1) was outside the 95% CI 
of HFRSh(a); table 2). By contrast, changes in the point 
estimates for each subsequent increase in the number of 
previous admissions (HFRSh(a + 2,1), HFRS
h
(a + 3,1), HFRS
h
(a + 4,1), 
and HFRSh(a + n,1)) were not significant (table 2); therefore, 
no significant change was observed in predictive power 
associated with the use of diagnostic data from any of 
Low frailty risk Intermediate frailty 
risk
High frailty risk
Current admission alone (a) 373 799 (55·4%) 251 009 (37·2%) 49 807 (7·4%)
HFRS 1-year window
Current admission plus previous 
admission in preceding year 
(a + 1,1)
301 882 (44·7%) 270 652 (40·1%) 102 081 (15·1%)
Current admission plus previous 2 
admissions in preceding year 
(a + 2,1)
283 891 (42·1%) 262 129 (38·9%) 128 595 (19·1%)
Current admission plus previous 3 
admissions in preceding year 
(a + 3,1)
278 364 (41·3%) 256 593 (38·0%) 139 658 (20·7%)
Current admission plus previous 4 
admissions in preceding year 
(a + 4,1)
276 330 (41·0%) 254 017 (37·7%) 144 268 (21·4%)
Current admission plus previous n 
admissions in preceding year 
(a + n,1)
274 419 (40·7%) 251 491 (37·3%) 148 705 (22·0%)
HFRS 2-year window
Current admission plus previous 
admission in preceding 2 years 
(a + 1,2)
288 411 (42·8%) 275 278 (40·8%) 110 926 (16·4%)
Current admission plus previous 2 
admissions in preceding 2 years 
(a + 2,2)
263 432 (39·0%) 263 944 (39·1%) 147 239 (21·8%)
Current admission plus previous 3 
admissions in preceding 2 years 
(a + 3,2)
254 826 (37·8%) 254 875 (37·8%) 164 914 (24·4%)
Current admission plus previous 4 
admissions in preceding 2 years 
(a + 4,2)
251 347 (37·3%) 249 942 (37·0%) 173 326 (25·7%)
Current admission plus previous n 
admissions in preceding 2 years 
(a + n,2) 
247 640 (36·7%) 243 487 (36·1%) 183 488 (27·2%)
Percentages are proportions of a total of 674 615 observations. HFRS=Hospital Frailty Risk Score. 
Table 3: Proportion of patients in each frailty risk category under different forms of the HFRS
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these past admissions to construct the HFRS. This 
indicates that, if restricted to a single year’s worth of 
data, data from the current and previous admission 
(HFRS(a + 1,1)) are sufficient to predict long length of stay. 
Applying the same strategy, we found that the preferred 
construction was HFRS(a + 2,1) for in-hospital death and 
HFRS(a + 1,1) for 30-day readmissions (figure 2B, C).
In the third stage, we tested whether using a 2-year 
window offered greater accuracy. We observed that, 
compared with a 1-year window, a 2-year window resulted 
in larger proportions of patients categorised as having 
high frailty risk under each form of the HFRS (table 3).
We plotted the proportion of patients in the high 
frailty risk category against the OR (95% CI) for long 
length of stay under each version of the 2-year window 
HFRS (figure 2A). Using a 2-year window, the predictive 
power of high frailty risk on long length of stay was 
lower than that predicted when using a 1-year window 
(table 2). Within a 1-year window, the HFRSh(a + 1,1) was 
preferred for predicting long length of stay. The point 
estimate for the 2-year form, HFRSh(a + 1,2), was outside 
the 95% CI for HFRSh(a + 1,1), indicating that predictive 
accuracy improved with the use of 2-years’ worth of 
data (table 2; figure 2A). Assessing the subsequent 
versions of HFRS, we then established that the point 
estimate for HFRSh(a + 2,2) was outside the 95% CI for 
HFRSh(a + 1,2), whereas the point estimates for HFRS
h
(a + 3,2), 
HFRSh(a + 4,2), and HFRS
h
(a + n,2) all were within the 95% CI 
for HFRSh(a + 2,2). These findings imply that, to predict 
long length of stay accurately, it is best to construct 
HFRS(a + 2,2), the version that uses diagnostic data from 
the current and previous two admissions that occurred 
in the preceding 2 years. 
For in-hospital deaths and 30-day readmissions, our 
analyses reached the same conclusion as for long 
length of stay, with the point estimate for HFRSh(a + 2,2) 
lying outside the 95% CI for HFRSh(a + 2,1) (figure 2B, C). 
These findings mean that the HFRS(a + 2,2) construction 
was the optimal form of the HFRS for all three outcomes. 
The HFRS(a + 2,2) form was also preferred when the look-
back window was widened to 3 years, with the predictions 
for the 2-year and 3-year windows almost exactly the 
same for all three outcomes (appendix p 12). This finding 
implies that no additional significant information was 
gained by applying a 3-year compared with a 2-year 
window. By extension, this ruled out the need to look 
even further back in time.
Under this HFRS(a + 2,2) form, of the 674 615 observa tions, 
263 432 (39·0%) were classified as low frailty 
risk, 263 944 (39·1%) as intermediate frailty risk, and 
147 239 (21·8%) as high frailty risk. For the 
263 432 observations with low frailty risk, 33 333 (12·7%) 
resulted in a long length of stay, 10 145 (3·9%) in in-
hospital death, and 45 226 (17·2%) in readmission within 
30 days. Compared with observations with low frailty 
risk, the probability for observations with intermediate 
frailty risk was 2·5-times higher for long length of stay 
(95% CI 2·4 to 2·6), 2·17-times higher for in-hospital 
death (2·1 to 2·2), and 0·7% higher for readmission 
(0·5% to 1). For observations with high frailty risk, the 
probability was 4·3-times higher (4·2 to 4·5) for long 
length of stay, 2·48-times higher (2·4 to 2·6) for in-
hospital death, and –1% (–1·2 to –0·5) lower for 
readmission, compared with observations with low frailty 
risk. 
Full regression results for the three outcomes when 
using the HFRS(a + 2,2) construction are reported in the 
appendix (p 7) and summarised as forest plots (figure 3). 
The intermediate and high frailty risk categories were 
more important predictors of long length of stay than 
any of the other patient or pathway characteristics 
Figure 2: HFRSh estimates for length of stay (>10 days; A), in-hospital deaths (B), and 30-day readmissions  
(C) within 1 year and 2 years
(a)=current admission. (a + n)=current admission and n previous admissions. h=high-risk group. HFRS=Hospital 
Frailty Risk Score.
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considered, none of which influenced long length of 
stay by more than 2·2-times their reference categories 
(figure 3A). The importance of the HFRS as a predictor 
held when examining the probability of length of stay 
in excess of 7 days and 21 days (appendix pp 8–9). For 
predicting in-hospital death, the Charlson Comorbidity 
Index was the most important (particularly for scores of 
3 up to the maximum of 24 [HR 3·71]), followed by the 
frailty risk categories (figure 3B). The probability of 
dying in hospital also increased with age (HR 1·73 for 
patients older than 95 years) and for patients who were 
admitted with an ACSC (HR 1·55), and it increased 
with increasing urgency of the patient´s condition as 
designated by the call handler (HR 1·75 for patients 
with a life-threatening condition; figure 3B).
The probability of 30-day readmission was higher for 
more previous admissions to hospital (17% higher if 
three or more in the preceding year) and for higher 
Charlson scores (2·7% higher for scores of three or 
higher; figure 3C). Patients living in care homes 
were 1·5% less likely to be readmitted. Compared with 
patients with low frailty risk, those with intermediate 
frailty risk were 1% more likely to be readmitted and 
those with high frailty risk were 1% less likely to be 
readmitted (figure 3C).
Discussion
The HFRS has been widely applied, but studies 
have inconsistently used previous admissions in its 
construction. In our study, we considered various forms of 
the HFRS to determine the minimum amount of 
diagnostic data to be used. Our assessment was based on 
whether there are significant changes in the ability of the 
high frailty risk marker to predict long length of stay, in-
hospital death, and 30-day readmission in our cohort of 
patients. We judged that predictive ability was not 
improved if the HFRSh point estimate from a form of the 
HFRS constructed with more diagnostic data was within 
the 95% CI of the HFRSh from the preceding version. 
We found that the preferred form of the HFRS to predict 
all three outcomes used diagnostic data from the current 
and previous two admissions in the preceding 2-years.
Being categorised as having intermediate or high frailty 
risk was a more important predictor of long length of 
stay than any of the other rich set of control variables 
included in our analysis. These categories also proved to 
Figure 3: Regression results for length of stay (>10 days; A), in-hospital deaths (B), and 30-day readmissions (C) for HFRS(a + 2,2)
(a + 2,2)=current admission plus 2 previous admissions in the preceding 2 years. ACSC=ambulatory care-sensitive conditions. ED=emergency department. HFRS=Hospital Frailty Risk Score. 
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be important predictors of in-hospital mortality, with 
only the Charlson Comorbidity Index offering greater 
predictive power. The observation that both the HFRS and 
Charlson categories were highly significant predictors 
when jointly considered shows that they capture different 
risk factors associated with in-hospital death. By contrast, 
frailty risk was not a strong predictor of 30-day 
readmission. The inability of the HFRS to predict 
readmission might be because of the care that patients 
who are frail receive: if post-discharge care packages are 
put in place to support these individuals when they 
return to their usual place of residence, then their risk of 
readmission might be reduced.
Our findings that the HFRS is a strong predictor of 
long length of stay and in-hospital death are in line 
with other studies that have applied the HFRS to older 
people.2,4 In agreement with some studies,3,4 but not 
with others,2,10 we found that the HFRS is not a strong 
predictor of readmission. Our study offers key 
advantages that make our predictions of frailty risk on 
outcomes more precise than those reported by other 
studies. The CUREd dataset covers 7 years, but data 
from the first 2 years were used solely to ensure that 
the HFRS was constructed consistently for all 
individuals. We benefited from a large sample size, 
thereby generating more precise estimates than those 
for small samples. Additionally, by linking individual 
data across emergency and urgent care settings, we 
controlled for a rich set of variables that might be 
correlated with frailty risk. Not accounting for these 
influences might over-estimate the impact of frailty 
risk on the outcomes.
Our study has limitations. The control variables can be 
improved, for instance by accounting for ethnicity—
known to be poorly coded in English hospital data25—and 
by use of better measures of socioeconomic status. The 
positive association between the HFRS and longer length 
of stay might be upwardly biased because patients with 
longer stays tend to have more extensive documentation 
of frailty-related diagnoses,26 although the use of three-
character rather than four-character ICD-10 codes offers 
some protection against this bias. The HFRS might not 
be feasible in health-care systems that do not routinely 
collect ICD-10 codes electronically. Although not a 
national study, our data are from a large, representative 
region of the UK.
Although no frailty tool discriminates well enough to 
direct clinical care at the individual patient level, tools can 
be used to identify cohorts at greater risk of poor 
outcomes.27 If embedded into hospital electronic health 
records, the HFRS could be used to target frailty 
interventions, avoiding the burden of implementing 
manual scores such as the Clinical Frailty Scale and 
improving the standardisation of frailty assessment. The 
combination of the electronic Frailty Index for primary 
care and HFRS for secondary care risk stratification 
would advance frailty-friendly care, as called for in various 
policy documents.28 The electronic Frailty Index and 
HFRS identify different at-risk cohorts, and thus their 
combination offers opportunity to identify the whole 
population at risk. Further research could examine how 
well the HFRS performs in other health-care systems, 
refine the HFRS through the incorporation of real-time 
data, and develop frailty-attuned clinical decision support 
systems.29
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